This article was originally published in SRA
ECJ rules that Swedish pharmacy monopoly is contrary to EU law
You may also be interested in...
The agency is waiving premarket notification requirements for coagulation systems to monitor COVID-19 patients who are at high risk for blood clotting.
In its “robust, holistic hub” online, firms in the VMS product supply chain can determine their needs, “by product, solution or delivery formats,” and use a “comprehensive and unique portfolio” to “turn natural sources into shelf-ready products.”
Plus deals involving Astellas/Actinium, Sosei/PharmEnable, Aadi/EOC Pharma, BeiGene/Strand, Chi-Med/Inmagene, Alteogen/Intas, Sosei/AbbVie, Y-Biologics/3D Medicines.